Opportunities for Nonclinical Statisticians in the Biopharmaceutical Industry
Explore the history and future of the ASA BioPharm Nonclinical Working Group (NCB), which aims to enhance statistical excellence in the biopharmaceutical field. Learn about the partnership with the ASA Biopharm Section, new opportunities, upcoming events, ties to ASA infrastructure, and valuable resources for nonclinical statisticians. Join a community dedicated to promoting statistical innovation in biopharmaceutical research.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
ASA BioPharm Nonclinical Working Group (NCB): New Opportunities Anthony Lonardo {Past Chair NCBLF } NCB 2017 Rutgers University 06/12/2017
History History In Oct of 2003, at Schering-Plough Research, a group of industry nonclinical statisticians in discovery, safety, development, and manufacturing recognized a need to promote excellence in statistics within these areas. Over the next 13 years, this informal group of nonclinical biostatistician leaders formed the Nonclinical Biostatistics Leadership Forum (NCBLF) and successfully promoted communication and discussion on important statistical and regulatory topics within the biopharmaceutical community. This group promoted activities including the creation of a nonclinical biostatistics conference (NCB) given every two years. However a lack of formal structure hindered the group s growth, and made it difficult to sponsor new initiatives. One possible solution was to partner with the ASA Biopharm Section (BIOP) First we had to convince the BIOP Section Executive Committee
Partnering: Partnering: A Team Effort A Team effort by the NCBLF steering team and NCBLF members Proposal to the Exec Committee was prepared by Stan Altan with help from Mandy Bergquist, Steve Novick, and input from other NCBLF members The proposal was presented to the Exec Committee by Gary Sullivan and Mandy Bergquist Special thanks to BIOP Exec Committee Past Chair{ Christine Clark }, the current Chair { Alex Dmitrienko }, and Bill Pikounis {current Exec Com member} This process took about 9 months The BIOP Exec Committee welcomed us at their Oct, 2016 meeting
The Future: The Future: Many New Opportunities New BioPharm Exec Committee members NCB Conference Chair NCB Working Group Chair Ad Hoc member not tied to NCB { Steve Novick } { Mandy Bergquist} { Tony Lonardo} Funding NCB Conference The Exec committee is open to other good ideas ( Workshops ? )
Ties Ties to ASA to ASA Infrastructure Infrastructure Media Our own NCB Web Site {Thank you Steve Novick and Richard Zink } http://community.amstat.org/biop/events/ncb/index WebCast Links Publications Library ASA group initiatives { for example mentoring} http://magazine.amstat.org/blog/2017/05/01/biopharm-section-mentoring/
An invitation An invitation Many opportunities for nonclinical statisticians Looking for ideas, energy, skills, and passions We invite you to get involved to take advantage of these opportunities. Interested ? Contact conference steering team members.
